5Kircik LH. Re -evaluating treatment targets in acne vulgaris:adapting to a new understanding of pathophysiology [J]. J DrugsDermatol, 2014, 13(6): s57-s60.
6Norris JF, Cunliffe WJ. A histological and immunocytochemicalstudy of early acne lesions [J]. Br J Dermatol, 1988, 118(5):651-659.
7Jeremy AH, Holland DB, Roberts SG, et al. Inflammatory eventsare involved in acne lesion initiation[J]. J Invest Dermatol, 2003,121(1): 20-27.
8Del RJ, Kircik LH. The sequence of inflammation, relevantbiomarkers, and the pathogenesis of acne vulgaris: what does re-c-ent research show and what does it mean to the dink_ian.[J|. JDrugs Dermatol. 2013, 12(8 Suppl) : sl()9-sl 15.
9Kang S, Cho S, Chung JH. et al. Inflammation and extracellularmatrix degradation mediate(丨 by activated transcription factors nu-clear factor-kappaB and activator protein-1 in inflammatory acnelesions in vivo[J]. Am J Pathol. 2005, 166(6) ; 1691-1699.
10Trivetli NR, Gilliland KL, Zhao W, et al. Gene array expressionprofiling in acne lesions reveals marked upregulation of genesinvolved in inflammation and matrix remodeling!J |. J Invest Der-matol. 2006, 126(5): 1071-1079.
